Why is Ajanta Pharma falling/rising?

As of 04-Jul, Ajanta Pharma Ltd. is experiencing a price increase, currently at Rs 2,701.55, which reflects a rise of 76.75 or 2.92%. The stock has shown strong performance today, outperforming its sector by 2.41% and achieving a consecutive gain over the last three days with a total return of 7.85% during this period. In terms of longer-term performance, Ajanta Pharma has delivered a return of 21.68% over the past year, significantly surpassing the broader market's return of 2.13%. The stock is currently trading above its 5-day, 20-day, 50-day, and 100-day moving averages, although it remains below its 200-day moving average. However, there has been a notable decline in investor participation, with delivery volume dropping by 42.06% compared to the 5-day average.
In the broader market context, Ajanta Pharma's recent gains contrast sharply with the Sensex, which has declined by 0.74% over the past week. This divergence highlights the stock's resilience and market-beating performance, particularly given its high management efficiency, as evidenced by a return on equity of 22.06%, and a low debt-to-equity ratio. Additionally, the stock benefits from high institutional holdings at 26.35%, indicating strong confidence from knowledgeable investors. Despite the recent positive price movement, the decrease in delivery volume suggests caution among retail investors, which could impact future price stability.